Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities

Bioorganic & Medicinal Chemistry Letters
Kohei HayashidaHiroshi Nagase

Abstract

We recently reported oxazatricyclodecane derivatives 1 as δ opioid receptor (DOR) agonists having a novel chemotype, but their DOR agonistic activities were relatively low. Based on the working hypothesis that the dioxamethylene moiety in 1 may be an accessory site and that it may interfere with the sufficient conformational change of the receptor required for exerting the full agonistic responses, we designed and synthesized new oxazatricyclodecane derivatives 2-4 lacking the dioxamethylene moiety. As we expected, the designed compounds 2-4 showed pronouncedly improved agonistic activities for the DOR. Compound 2a with the 17-cyclopropylmethyl substituent was a potent agonist with the highest selectivity for the DOR and was expected to be a lead compound for novel and selective DOR agonists.

References

Jun 1, 1990·Journal of Medicinal Chemistry·P S PortogheseA E Takemori
Jun 30, 2005·Journal of the American Chemical Society·James L DyeMichael Lefenfeld
Oct 3, 2008·Bioorganic & Medicinal Chemistry·Koji KawaiHiroshi Nagase
Nov 1, 2008·Organic Letters·Partha NandiJames E Jackson
Apr 14, 2009·Bioorganic & Medicinal Chemistry Letters·Hiroshi NagaseShuichi Hirono
Jul 6, 2010·Drug Discovery Today·Clay W Scott, Matthew F Peters
Sep 21, 2010·Bioorganic & Medicinal Chemistry Letters·Hiroshi NagaseHideaki Fujii
Jan 25, 2011·Bioorganic & Medicinal Chemistry·Toru NemotoHiroshi Nagase
Jun 2, 2011·Topics in Current Chemistry·Hiroshi Nagase, Hideaki Fujii
May 28, 2013·Expert Opinion on Therapeutic Patents·Hideaki FujiiHiroshi Nagase
Jun 6, 2014·ACS Medicinal Chemistry Letters·Hideaki FujiiHiroshi Nagase
Nov 26, 2014·Journal of Pharmacological Sciences·Kanako MiyanoYasuhito Uezono

❮ Previous
Next ❯

Citations

Dec 6, 2019·Peptides·Richard J Bodnar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.